These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2446057)

  • 1. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients: an international multicenter trial.
    Zin C; Copertari P; Landi E; San Martin C; Lopes M; Feruglio F; Alcocer L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S113-8. PubMed ID: 2446057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketanserin versus nifedipine in the treatment of essential hypertension in patients over 50 years old: an international multicenter study.
    Hannedouche T; Fillastre JP; Mimran A; de Tréglodé D; Schardt F; Rosenthal T; Grossman E; Rocco S
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S107-12. PubMed ID: 2446056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.
    Janssens M; Symoens J
    J Hypertens Suppl; 1986 Dec; 4(6):S115-8. PubMed ID: 3302148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketanserin in mild to moderate hypertension in the elderly: a double-blind study versus methyldopa.
    Cattin L; Da Col PG
    Clin Ther; 1989; 11(3):363-72. PubMed ID: 2663164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter study with ketanserin in essential hypertension: an Argentine experiment.
    Demartini A; Pezzano R; Bernardiner E; Torres J; Genta C; Scheijgrond H; Gypen L
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S135-7. PubMed ID: 2446062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketanserin versus alpha-methyldopa in the treatment of hypertension during pregnancy: a preliminary report.
    Voto LS; Zin C; Neira J; Lapidus AM; Margulies M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S101-3. PubMed ID: 2446054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with ketanserin in the treatment of hypertension.
    Palermo A; Mara G; Pizza N; Costantini C; del Rosso G; Assogna G; Libretti A
    J Hypertens Suppl; 1986 Apr; 4(1):S81-3. PubMed ID: 2939219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of ketanserin on arterial pressure at rest and during physical exercise in essential arterial hypertension].
    Gambini G; Gradoli C; Proietti MG; Pinchi G; Fioroni E; Valori C
    Clin Ter; 1989 Jul; 130(2):101-7. PubMed ID: 2529082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive efficacy of ketanserin alone or in combination with a beta-blocker or a diuretic: the Swiss Ketanserin Study.
    Beretta-Piccoli C; Amstein R; Bertel O; Brunner HR; Bühler FR; Follath F; Solèr M; Vallotton M
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S119-23. PubMed ID: 2446058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood pressure lowering action and tolerance of ketanserin in mono- or combination therapy].
    Beretta-Piccoli C; Amstein R; Bühler FR; Bertel O; Brunner HR; Follath F; Reutter F; Vallotton MB
    Schweiz Med Wochenschr; 1989 Mar; 119(12):399-406. PubMed ID: 2711155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of captopril and methyldopa monotherapy for hypertension: double-blind study in Indians.
    Tahiliani R; Khokhani RC; Damle VB; Dadkar VN; Jaguste VS; Patel K; Raghu CN; Oke VG
    Clin Ther; 1986; 8(5):482-9. PubMed ID: 3533264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term antihypertensive efficacy of ketanserin plus chlorthalidone.
    Fasano ML; Soro S; Ferrara LA
    Drugs Exp Clin Res; 1989; 15(11-12):587-90. PubMed ID: 2700322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antihypertensive effects of ketanserin and a ketanserin-hydrochlorothiazide combination administered once daily.
    Leary WP; Reyes AJ; van der Byl K; Maharaj B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S127-34. PubMed ID: 2446061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
    Whelton PK; Russell RP; Sova-Schulz K; Wyndham R; Walker WG
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S28-37. PubMed ID: 94637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketanserin versus metoprolol in the treatment of essential hypertension.
    Milei J; Lemus J; Bernardiner E
    J Hypertens Suppl; 1986 Apr; 4(1):S77-9. PubMed ID: 2939218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical investigation of the effect of ketanserin: a new antihypertensive drug.
    Coto V; Oliviero U; Cocozza M; Lucariello A; Picano T; Coto F; Cacciatore L
    Drugs Exp Clin Res; 1989; 15(5):231-4. PubMed ID: 2676440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.